LeafNLP Demos
Back to explore

Report #2872428

Received Nov 13, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
AL
Recovered
Unknown
Vaccinated
Jul 26, 2025
Onset
Oct 30, 2025
Days to onset
96
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1——

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

No other AE/No PQC; first dose of GARDASIL 9 on 26JUL2025 but did not come in at the 2 month mark to receive his second dose (should have been received 26SEP2025). His second dose will be given today 30OCT2025; This spontaneous report was received from pharmacist and refers to 39-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 26-Jul-2025, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) dose number 1, 0.5 mL, as prophylaxis (lot # and expiration date were not reported). The patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), for the treatment of prophylaxis. The patient did not come in at the 2 month mark to receive his second dose (should have been received 26-SEP-2025). His second dose will be given today 30-OCT-2025 instead (inappropriate schedule of product administration). No other adverse event (AE)/No product quality complaint (PQC).